Independent service organization Serviscope has expanded its reachin the northern Virginia, Washington, DC, and Baltimore areasby acquiring Certified X-ray, a small ISO based in Centerville,VA. Serviscope, of Wallingford, CT, said the acquisition is
Independent service organization Serviscope has expanded its reachin the northern Virginia, Washington, DC, and Baltimore areasby acquiring Certified X-ray, a small ISO based in Centerville,VA. Serviscope, of Wallingford, CT, said the acquisition is partof its plan to expand into new regional markets.
Certified X-ray focuses on maintaining GE x-ray equipment andspecializes in x-ray room moves and on-site refurbishing, accordingto Thomas Tierney, Serviscope CFO. The company also has severaltime-and-materials service contracts with luminary hospitals.
Serviscope was attracted to Certified because it offered accessto a market in which Serviscope did not have a presence. The acquisitionwas made using Serviscope stock and the company will bring allCertified employees under its wing, including president ScottStarkey.
Serviscope continues to target new acquisitions as part ofits growth strategy. The company is primarily looking at ISOsin new regional markets and at in-house service departments athospitals, Tierney said. Serviscope unveiled its AssetCare multivendorservice and asset management program in May, and plans to useacquisition to expand the types of equipment it is capable ofservicing under the program (SCAN 6/21/95).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.